TrialBioMed research international2021

Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open-Labeled Trial.

Lan-Lan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.